IVF at 42: Own Eggs, Donor Eggs and the Questions That Matter

AMH and antral follicle count provide information about the likely number of eggs retrieved during stimulation, not the chromosome status of those eggs. Egg age is a separate consideration that influences the likelihood of embryo chromosome errors and reproductive outcomes at the population level. A normal AMH does not make 42 biologically equivalent to 32. Conversely, a low reserve marker cannot by itself rule out an individual outcome. A clinician should interpret age alongside previous ovarian response, pregnancy history and relevant medical findings.

If IVF was tried before, obtain the stimulation, retrieval and embryology reports. How many follicles developed? How many eggs were mature? Were there fertilised embryos, blastocysts or embryos placed in storage? These details can help identify which step is most uncertain. An unsuccessful attempt does not prove all future attempts will fail, but repeating a costly protocol without examining prior results may be hard to justify. Ask which concrete change, if any, the clinician recommends and what evidence supports that change.

Donor eggs may be discussed when a patient’s circumstances make the chance of using their own eggs particularly limited or when another medical indication exists. Donor treatment is not simply a higher-priced version of IVF. It raises consent, donor screening, legal eligibility, embryo ownership, counselling and disclosure questions. Pregnancy health risks related to the recipient’s age and medical conditions still need assessment. Services and legal requirements in India must be verified with the actual registered treating centre and qualified advisers; no donor availability should be presumed.

Ask any clinic whether reported results refer to pregnancy tests, clinical pregnancies or live births, and whether the denominator is started cycles, egg retrievals or embryo transfers. Per-transfer figures can omit people whose cycle produced no transferable embryo. Donor and own-egg statistics may also use different patient groups. A responsible doctor explains these distinctions without presenting population averages as your personal percentage. Do not accept a guaranteed “baby package” claim or an unverified testimonial as clinical evidence.

A full comparison should list consultation, investigations, medication, monitoring, egg retrieval, laboratory work, potential donor-related charges where lawful, embryo storage, transfer and follow-up. Ask what happens financially if an own-egg cycle is cancelled or produces no embryo. Discuss what number of attempts, financial exposure and recovery periods would feel acceptable. Counselling is useful whether a person chooses more treatment, donor treatment, a pause or another family-building route. A choice is not a medical failure.

HomeIVF is positioned as doctor-led fertility care designed to reduce unnecessary visits. Reviewing earlier cycles and discussing options may be appropriate remotely. Selected home blood collection or prescribed-injection support can be considered only where the service is confirmed and the doctor approves it. Required scans, egg retrieval, embryology, any donor-related clinical procedures and embryo transfer remain facility-based. More convenient coordination should not replace careful consent or individualised pregnancy-risk assessment.

Ask your clinician to write down the working diagnosis, which evidence supports it, the treatment options discussed and what result would actually change the plan. Confirm whether both partners have been appropriately assessed, what tests are necessary rather than merely available, who reviews time-sensitive findings and what happens when a cycle does not go as hoped. Request a complete estimate of investigation, medication, monitoring, facility and laboratory charges. Decisions should be framed as informed choices under uncertainty rather than sales deadlines or promised success.

HomeIVF is a doctor-led, home-supported fertility-care model intended to reduce unnecessary clinic visits rather than replace clinical IVF. Depending on medical needs and confirmed local availability, teleconsultations, selected home blood collection and help administering prescribed injections may be possible. None is promised for every patient or location. Required ultrasounds and examinations, clinical IUI, sperm retrieval, egg retrieval, embryology and embryo transfer must take place in appropriate facilities. Home services must follow the treating clinician’s orders and the laboratory’s timing and quality requirements. A patient with urgent symptoms needs an appropriate emergency service, not an online appointment.